万孚生物（300482）8月25日主力资金净流出6270.82万元

Core Insights - The stock price of Wanfu Biology (300482) closed at 23.1 yuan on August 25, 2025, with a slight decrease of 0.04% [1] - The company reported a total revenue of 1.246 billion yuan for the first half of 2025, representing a year-on-year decrease of 20.92% [1] - Wanfu Biology's net profit attributable to shareholders was 189 million yuan, down 46.82% year-on-year [1] Financial Performance - Total revenue for the first half of 2025: 1.246 billion yuan, down 20.92% year-on-year [1] - Net profit attributable to shareholders: 189 million yuan, down 46.82% year-on-year [1] - Non-recurring net profit: 154 million yuan, down 52.73% year-on-year [1] - Current ratio: 5.717 [1] - Quick ratio: 5.130 [1] - Debt-to-asset ratio: 18.44% [1] Market Activity - The trading volume was 152,800 hands, with a transaction amount of 353 million yuan [1] - Main funds experienced a net outflow of 62.71 million yuan, accounting for 17.75% of the transaction amount [1] - Large orders saw a net outflow of 40.16 million yuan, representing 11.37% of the transaction amount [1] Company Background - Wanfu Biology was established in 1992 and is located in Guangzhou, primarily engaged in the pharmaceutical manufacturing industry [2] - The company has made investments in 37 enterprises and participated in 1,581 bidding projects [2] - The company holds 397 trademark registrations and 729 patents, along with 1,822 administrative licenses [2]